Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up-Reply.
作者信息
Ferrara Pietro, Antonazzo Ippazio C, Polosa Riccardo
机构信息
Center for Public Health Research, University of Milan-Bicocca, Via Cadore 48, 20900, Monza, Italy.
IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
出版信息
Intern Emerg Med. 2022 Jan;17(1):313-314. doi: 10.1007/s11739-021-02911-9. Epub 2022 Jan 10.
Abstract
摘要
相似文献
1
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up-Reply.意大利医护人员对BNT162b2 mRNA新冠疫苗的反应：3个月随访——回复
Intern Emerg Med. 2022 Jan;17(1):313-314. doi: 10.1007/s11739-021-02911-9. Epub 2022 Jan 10.
2
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment.意大利医护人员对BNT162b2 mRNA新冠疫苗的反应：3个月随访：评论
Intern Emerg Med. 2022 Jan;17(1):311-312. doi: 10.1007/s11739-021-02907-5. Epub 2022 Jan 10.
3
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up.意大利医护人员对 BNT162b2 mRNA COVID-19 疫苗的反应：3 个月随访。
Intern Emerg Med. 2022 Mar;17(2):481-486. doi: 10.1007/s11739-021-02857-y. Epub 2021 Oct 12.
4
Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.BNT162b2疫苗在意大利布雷西亚医护人员中针对SARS-CoV-2 B.1.1.7变体的有效性。
J Infect. 2021 Jul;83(1):e17-e18. doi: 10.1016/j.jinf.2021.04.038. Epub 2021 May 7.
5
Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.意大利米兰一家 COVID-19 转诊医院的医护人员中既往感染状况对 BNT162b2 mRNA COVID-19 疫苗抗体反应的影响。
Hum Vaccin Immunother. 2021 Dec 2;17(12):4747-4754. doi: 10.1080/21645515.2021.2002639. Epub 2022 Jan 27.
6
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.使用索灵SARS-CoV-2 S-RBD IgG化学发光免疫分析法监测医护人员对辉瑞BNT162b2 mRNA新冠疫苗的免疫反应。
Clin Chem Lab Med. 2021 Jun 23;59(10):e377-e379. doi: 10.1515/cclm-2021-0687. Print 2021 Sep 27.
7
Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.BNT162b2 mRNA COVID-19 疫苗的抗体反应动力学：7 个月随访研究。
Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.
8
Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.接种一剂 BNT162b2 mRNA 新冠疫苗后对 SARS-CoV-2 感染的免疫反应：一项意大利前瞻性观察研究。
Vaccine. 2022 Mar 15;40(12):1805-1809. doi: 10.1016/j.vaccine.2022.02.002. Epub 2022 Feb 16.
9
Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.BNT162b2 mRNA 冠状病毒病 2019（COVID-19）疫苗在长期护理机构医护人员中预防严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）获得性感染的有效性：一项前瞻性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e755-e763. doi: 10.1093/cid/ciab918.
10
Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers.BNT162b2 mRNA 新冠疫苗在西班牙医护人员中的有效性。
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan;41(1):33-35. doi: 10.1016/j.eimce.2022.11.010.
引用本文的文献
1
Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study.新冠mRNA疫苗加强剂量后反复出现不良反应的风险：MOSAICO研究结果
Vaccines (Basel). 2023 Jan 22;11(2):247. doi: 10.3390/vaccines11020247.
2
Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study.mRNA新冠疫苗加强剂量后混合免疫对突破性感染风险的时变效应：MOSAICO研究
Vaccines (Basel). 2022 Aug 19;10(8):1353. doi: 10.3390/vaccines10081353.
3
The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies.吸烟对新冠疫苗体液免疫反应的影响：流行病学研究的系统评价
Vaccines (Basel). 2022 Feb 16;10(2):303. doi: 10.3390/vaccines10020303.
本文引用的文献
1
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study.T 细胞和抗体对先前感染和 SARS-CoV-2 阴性的英国医护人员第一剂 BNT162b2 疫苗的反应：一项多中心前瞻性队列研究。
Lancet Microbe. 2022 Jan;3(1):e21-e31. doi: 10.1016/S2666-5247(21)00275-5. Epub 2021 Nov 9.
2
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.6个月后对BNT162b2 mRNA新冠疫苗抗体反应的动态变化
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.
3
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up.意大利医护人员对 BNT162b2 mRNA COVID-19 疫苗的反应：3 个月随访。
Intern Emerg Med. 2022 Mar;17(2):481-486. doi: 10.1007/s11739-021-02857-y. Epub 2021 Oct 12.
4
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
Zotero 插件